Variable ALK Protein and ALK Gene Staining in Inflammatory Myofibroblastic Tumors

被引：1
|
作者：
Katzman, Philip J. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
来源：
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY | 2013年 / 16卷 / 03期
关键词：
EXPRESSION;
D O I：
10.2350/13-03-1311-LET.1
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：232 / 233
页数：2
相关论文
共 50 条
  • [21] Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives
    Theilen, Till-Martin
    Soerensen, Jan
    Bochennek, Konrad
    Becker, Martina
    Schwabe, Dirk
    Rolle, Udo
    Klingebiel, Thomas
    Lehrnbecher, Thomas
    PEDIATRIC BLOOD & CANCER, 2018, 65 (04)
  • [22] ALK positive inflammatory myofibroblastic tumour of the pineal region
    Clarke, AJ
    Jacques, TS
    Galloway, MJ
    Thom, M
    Kitchen, ND
    Plant, GT
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (09) : 981 - 983
  • [23] Crizotinib in ALK-Rearranged Inflammatory Myofibroblastic Tumor
    Butrynski, James E.
    D'Adamo, David R.
    Hornick, Jason L.
    Dal Cin, Paola
    Antonescu, Cristina R.
    Jhanwar, Suresh C.
    Ladanyi, Marc
    Capelletti, Marzia
    Rodig, Scott J.
    Ramaiya, Nikhil
    Kwak, Eunice L.
    Clark, Jeffrey W.
    Wilner, Keith D.
    Christensen, James G.
    Jaenne, Pasi A.
    Maki, Robert G.
    Demetri, George D.
    Shapiro, Geoffrey I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (18): : 1727 - 1733
  • [24] A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate
    Owusu-Brackett, Nicci
    Johnson, Romaine
    Schindel, David T.
    Koduru, Prasad
    Cope-Yokoyama, Sandy
    CANCER GENETICS, 2013, 206 (9-10) : 353 - 356
  • [25] Effectiveness of Crizotinib for Inflammatory Myofibroblastic Tumor with ALK mutation
    Ogata, Misato
    Hatachi, Yukimasa
    Ogata, Takatsugu
    Satake, Hironaga
    Imai, Yukihiro
    Yasui, Hisateru
    INTERNAL MEDICINE, 2019, 58 (07) : 1029 - 1032
  • [26] Assessment of ALK Fusions in Uncommon Inflammatory Myofibroblastic Tumors With ALK IHC Positivity but FISH-Equivocal Findings by Targeted RNA Sequencing
    Yao, Qianlan
    Bai, Qianming
    Zhang, Xin
    Ji, Gang
    Chang, Heng
    Cai, Xu
    Yu, Lin
    Wang, Jian
    Zhu, Xiaoli
    Zhou, Xiaoyan
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2022, 146 (10) : 1234 - 1242
  • [27] A Case Report of Epithelioid Inflammatory Myofibroblastic Sarcoma with RANBP2-ALK Fusion Gene Treated with the ALK Inhibitor, Crizotinib
    Kimbara, Shiro
    Takeda, Koji
    Fukushima, Hiroko
    Inoue, Toru
    Okada, Hideaki
    Shibata, Yumi
    Katsushima, Utae
    Tsuya, Asuka
    Tokunaga, Shinya
    Daga, Haruko
    Okuno, Takahiro
    Inoue, Takeshi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (09) : 868 - 871
  • [28] A Case of ALK-Rearranged Inflammatory Myofibroblastic Tumor of the Bladder with Remarkable Response to ALK Inhibitor
    Sakai, Yuta
    Ikawa, Yasuhiro
    Takenaka, Mika
    Noguchi, Kazuhiro
    Fujiki, Toshihiro
    Kuroda, Rie
    Nomura, Kozo
    Sakai, Seisho
    Wada, Taizo
    PEDIATRIC BLOOD & CANCER, 2021, 68
  • [29] Fusion of ALK to the ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor
    Ma, ZG
    Hill, DA
    Collins, MH
    Morris, SW
    Sumegi, J
    Zhou, M
    Zuppan, C
    Bridge, JA
    GENES CHROMOSOMES & CANCER, 2003, 37 (01): : 98 - 105
  • [30] Fusion of ALK to the ran-binding protein 2 (RanBP2) gene in inflammatory myofibroblastic tumor
    Ma, Z
    Hill, DA
    Collins, MH
    Morris, SW
    Sumegi, J
    Zhou, M
    Zuppan, C
    Bridge, JA
    MODERN PATHOLOGY, 2003, 16 (01) : 302A - 302A
12345